FDA Approves First Drug to Reverse Aging Genes
The FDA has authorized the first human trials for ER-100 a drug designed to reverse aging by targeting specific genes.…
Groundbreaking Tooth Regrowth Drug in Phase 1 Clinical Trials
Discover the cutting-edge world of dental innovation with a drug poised to regrow human teeth, tackling tooth loss and…
The Role of Creatine in Reducing Anxiety Levels in Women
Creatine, renowned for enhancing muscle strength, offers mental health benefits. Women, in particular, may find that cr…
Metformin: Could This Diabetes Drug Slow Aging?
Metformin, a common type 2 diabetes drug, is being studied for its potential to slow aging and reduce the risk of relat…
Dr. David Sinclair: NMN Supplement Benefits Revealed
NMN, a precursor to NAD, is a supplement showing promise in supporting healthy aging by boosting NAD levels, which decl…
NMN's Potential in Treating Rare Diseases
NMN and NR, precursors to a crucial metabolic coenzyme, may offer new hope for treating rare diseases. Prominent resea…
Dr. Sinclair: Why NMN is Superior to NR for Boosting NAD
Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are both NAD precursors, but NMN offers a more efficie…
NMN Supplement: Boosting Insulin Sensitivity for Longevity
Improve insulin sensitivity, the body's responsiveness to insulin, with the supplement NMN, which boosts NAD+ levels to…
FDA Clears First Human Trial for Age Reversal
The FDA has approved the first human clinical trial targeting age reversal, a significant step in treating aging as a c…
Exploring Revolutionary Breakthroughs in Human Longevity
Recent advancements in longevity technology are challenging the inevitability of aging by aiming to reverse age-related…
Metformin's Surprising Benefits for Longevity and Diabetes
Metformin, primarily prescribed for type 2 diabetes, has recently shown promise as a potential longevity enhancer and p…
Groundbreaking Human Trials Aim to Reverse Aging
Human trials are underway to test the potential of reversing the aging process. The promise of this research lies in it…